JOURNAL OF CLINICAL IMMUNOLOGY, cilt.42, sa.5, ss.1036-1050, 2022 (SCI-Expanded)
Purpose Severe combined immunodeficiency (SCID) is one of the most severe forms of inborn errors of immunity characterized by absence or loss of function in T cells. The long-term outcomes of all forms of SCID have been evaluated in a limited number of studies. We aimed to evaluate the pre- and post-transplant manifestations of SCID patients and determine the factors affecting the survival of patients.